470 related articles for article (PubMed ID: 16087250)
1. In vitro and in vivo influenza virus-inhibitory effects of viramidine.
Sidwell RW; Bailey KW; Wong MH; Barnard DL; Smee DF
Antiviral Res; 2005 Oct; 68(1):10-7. PubMed ID: 16087250
[TBL] [Abstract][Full Text] [Related]
2. Treatment of mannan-enhanced influenza B virus infections in mice with oseltamivir, ribavirin and viramidine.
Smee DF; Wandersee MK; Wong MH; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2004 Sep; 15(5):261-8. PubMed ID: 15535048
[TBL] [Abstract][Full Text] [Related]
3. In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.
Sidwell RW; Smee DF; Huffman JH; Barnard DL; Bailey KW; Morrey JD; Babu YS
Antimicrob Agents Chemother; 2001 Mar; 45(3):749-57. PubMed ID: 11181355
[TBL] [Abstract][Full Text] [Related]
4. [In vitro and in vivo anti-influenza virus activity of ribavirin injection].
Gao RM; Li XQ; He WY; Jiang JD; Li YH
Yao Xue Xue Bao; 2010 Mar; 45(3):403-7. PubMed ID: 21351521
[TBL] [Abstract][Full Text] [Related]
5. Effects of TheraMax on influenza virus infections in cell culture and in mice.
Smee DF; Hurst BL; Wong MH
Antivir Chem Chemother; 2011 Jul; 21(6):231-7. PubMed ID: 21730370
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
Sidwell RW; Huffman JH; Barnard DL; Bailey KW; Wong MH; Morrison A; Syndergaard T; Kim CU
Antiviral Res; 1998 Feb; 37(2):107-20. PubMed ID: 9588843
[TBL] [Abstract][Full Text] [Related]
7. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-seiryu-to"--effects on aged mice, against subtypes of a viruses and B virus, and therapeutic effect.
Nagai T; Urata M; Yamada H
Immunopharmacol Immunotoxicol; 1996 May; 18(2):193-208. PubMed ID: 8771367
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of influenza virus replication by plant-derived isoquercetin.
Kim Y; Narayanan S; Chang KO
Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
[TBL] [Abstract][Full Text] [Related]
9. Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses.
Smee DF; Wong MH; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2006; 17(4):185-92. PubMed ID: 17066897
[TBL] [Abstract][Full Text] [Related]
10. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo protection against the highly pathogenic H5N1 influenza virus by an antisense phosphorothioate oligonucleotide.
Duan M; Zhou Z; Lin RX; Yang J; Xia XZ; Wang SQ
Antivir Ther; 2008; 13(1):109-14. PubMed ID: 18389905
[TBL] [Abstract][Full Text] [Related]
12. Utilization of alpha-1-acid glycoprotein levels in the serum as a parameter for in vivo assay of influenza virus inhibitors.
Sidwell RW; Wong MH; Bailey KW; Barnard DL; Jackson MK; Smee DF
Antivir Chem Chemother; 2001 Nov; 12(6):359-65. PubMed ID: 12018681
[TBL] [Abstract][Full Text] [Related]
13. Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201.
Sidwell RW; Smee DF; Huffman JH; Barnard DL; Morrey JD; Bailey KW; Feng WC; Babu YS; Bush K
Antiviral Res; 2001 Sep; 51(3):179-87. PubMed ID: 11448729
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice.
Barnard DL; Wong MH; Bailey K; Day CW; Sidwell RW; Hickok SS; Hall TJ
Antivir Chem Chemother; 2007; 18(3):125-32. PubMed ID: 17626596
[TBL] [Abstract][Full Text] [Related]
15. [Effect of anti-influenza virus H3N2 of Hypericum japonicum in vivo].
Liu N; Hu XL; Meng YR; Zhu YT; Huang BS; Lin PZ
Zhong Yao Cai; 2008 Jul; 31(7):1022-4. PubMed ID: 18973021
[TBL] [Abstract][Full Text] [Related]
16. In vivo ribavirin activity against severe pandemic H1N1 Influenza A/Mexico/4108/2009.
Rowe T; Banner D; Farooqui A; Ng DC; Kelvin AA; Rubino S; Huang SS; Fang Y; Kelvin DJ
J Gen Virol; 2010 Dec; 91(Pt 12):2898-906. PubMed ID: 20797971
[TBL] [Abstract][Full Text] [Related]
17. Anti-influenza virus effects of the aqueous extract from Mosla scabra.
Yu C; Yan Y; Wu X; Zhang B; Wang W; Wu Q
J Ethnopharmacol; 2010 Feb; 127(2):280-5. PubMed ID: 19914366
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice.
Sidwell RW; Huffman JH; Bailey KW; Wong MH; Nimrod A; Panet A
Antimicrob Agents Chemother; 1996 Nov; 40(11):2626-31. PubMed ID: 8913477
[TBL] [Abstract][Full Text] [Related]
19. Germacrone inhibits early stages of influenza virus infection.
Liao Q; Qian Z; Liu R; An L; Chen X
Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
[TBL] [Abstract][Full Text] [Related]
20. Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice.
Chen L; Dou J; Su Z; Zhou H; Wang H; Zhou W; Guo Q; Zhou C
Antiviral Res; 2011 Sep; 91(3):314-20. PubMed ID: 21782851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
